---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-212487"
form_type: "8-K"
ticker: "CRIS"
cik: "0001108205"
company_name: "CURIS INC"
filed_at: "2022-08-04T23:59:59+00:00"
generated_at: "2026-06-24T03:41:52.844029+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Curis Q2 net loss widens to $15.9M; appoints new CFO; emavusertib combo shows tumor reduction in 8 of 9

## Summary
- Net loss of $15.9M ($0.17/sh) vs $10.8M ($0.12) in Q2 2021; revenue flat at $2.4M.
- Cash and investments $107.2M as of June 30, 2022; cash runway expected into 2024.
- Emavusertib + ibrutinib combo: tumor reduction in 8 of 9 evaluable patients; 2 CR, 2 PR; potential to overcome ibrutinib resistance.
- Appointed Diantha Duvall as CFO effective Aug 5, 2022, succeeding Bill Steinkrauss (resigning).
- Working with FDA to resolve partial clinical holds on emavusertib enrollment.

## SEC filing metadata
- accession: 0001193125-22-212487
- form_type: 8-K
- ticker: CRIS
- cik: 0001108205
- company_name: CURIS INC
- filed_at: 2022-08-04T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1108205/000119312522212487/0001193125-22-212487-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1108205/000119312522212487/d249846d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-212487
- JSON: https://secwatch.observer/filing/0001193125-22-212487.json
- Plain text: https://secwatch.observer/filing/0001193125-22-212487.txt

## Key facts
- Executive change
  Diantha Duvall was appointed as Chief Financial Officer at CURIS INC.
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On August 4, 2022, the Board of Directors (the “Board”) of the Company appointed Diantha Duvall to the position of chief financial officer, treasurer, assistant secretary, principal financial officer and principal accounting officer of the Company effective as of August 5, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1108205/000119312522212487/0001193125-22-212487-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.